HilleVax Funding & Investors
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines. HilleVax was founded in 2021 and was headquartered in Boston, Massachusetts.
hillevax.comTotal Amount Raised: $235,000,000
HilleVax Funding Rounds
Post Ipo Equity
$100,000,000
Series Unknown
$135,000,000
Series Unknown Investors
AbingworthFranklin ResourcesDeerfield ManagementBiotechnology Value FundCatalys PacificQiming Venture Partners USASamsara BioCapitalSahsen VenturesFrazier ManagementPerceptive AdvisorsLightspeed Venture PartnersRA Capital ManagementGreenspring AssociatesRichard King Mellon Foundation
Funding info provided by Diffbot.